Alpha Teknova, Inc. (TKNO)
USD 6.52
(-1.36%)
USD 6.52
(-1.36%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -36.78 Million USD | 22.52% |
| 2022 | -47.46 Million USD | -384.22% |
| 2021 | -9.8 Million USD | -374.59% |
| 2020 | 3.57 Million USD | 373.56% |
| 2019 | -1.3 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -8.09 Million USD | 24.01% |
| 2024 Q2 | -5.36 Million USD | 33.75% |
| 2023 Q2 | -7.15 Million USD | 18.86% |
| 2023 Q1 | -8.81 Million USD | 33.68% |
| 2023 FY | -36.78 Million USD | 22.52% |
| 2023 Q4 | -10.65 Million USD | -4.95% |
| 2023 Q3 | -10.15 Million USD | -41.92% |
| 2022 Q2 | -6.2 Million USD | -12.84% |
| 2022 FY | -47.46 Million USD | -384.22% |
| 2022 Q1 | -5.49 Million USD | -50.73% |
| 2022 Q3 | -22.47 Million USD | -262.31% |
| 2022 Q4 | -13.29 Million USD | 40.85% |
| 2021 Q4 | -3.64 Million USD | -12.18% |
| 2021 Q1 | -655 Thousand USD | -213.52% |
| 2021 FY | -9.8 Million USD | -374.59% |
| 2021 Q2 | -2.25 Million USD | -243.51% |
| 2021 Q3 | -3.25 Million USD | -44.49% |
| 2020 Q1 | 948 Thousand USD | 0.0% |
| 2020 FY | 3.57 Million USD | 373.56% |
| 2020 Q4 | 577 Thousand USD | -62.36% |
| 2020 Q3 | 1.53 Million USD | 199.41% |
| 2020 Q2 | 512 Thousand USD | -45.99% |
| 2019 FY | -1.3 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 295.857% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -367.344% |
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 176.378% |
| Cosmos Health Inc. | -18.54 Million USD | -98.353% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -83.375% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 82.423% |
| Cronos Group Inc. | -73.96 Million USD | 50.272% |
| Incannex Healthcare Limited | -18.45 Million USD | -99.252% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 12.842% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 406.168% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -754.984% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -716.237% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -716.237% |
| SCYNEXIS, Inc. | 67.04 Million USD | 154.862% |
| Safety Shot Inc | -15.08 Million USD | -143.85% |
| Theratechnologies Inc. | -23.95 Million USD | -53.525% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -496.781% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 187.665% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -660.703% |
| Dynavax Technologies Corporation | -6.38 Million USD | -475.677% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 96.33% |
| Radius Health, Inc. | -25.79 Million USD | -42.608% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -1087.014% |
| Alvotech | -551.73 Million USD | 93.334% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 73.667% |
| SIGA Technologies, Inc. | 68.06 Million USD | 154.034% |
| Shineco, Inc. | -22.44 Million USD | -63.838% |
| Silver Spike Investment Corp. | 7.34 Million USD | 601.083% |
| Journey Medical Corporation | -3.85 Million USD | -854.581% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -350.559% |
| Embecta Corp. | 70.4 Million USD | 152.244% |
| Harrow Health, Inc. | -24.41 Million USD | -50.67% |
| Procaps Group, S.A. | 42.54 Million USD | 186.46% |
| Biofrontera Inc. | -20.13 Million USD | -82.703% |
| DURECT Corporation | -27.62 Million USD | -33.145% |
| PainReform Ltd. | -9.34 Million USD | -293.622% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 2894.833% |
| OptiNose, Inc. | -35.48 Million USD | -3.655% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 253.788% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 843.782% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -485.732% |
| ProPhase Labs, Inc. | -16.78 Million USD | -119.163% |
| Phibro Animal Health Corporation | 2.41 Million USD | 1622.351% |
| Procaps Group S.A. | 42.54 Million USD | 186.46% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -257.852% |
| Viatris Inc. | 54.7 Million USD | 167.239% |
| Rockwell Medical, Inc. | -8.43 Million USD | -335.834% |
| Aytu BioPharma, Inc. | -15.84 Million USD | -132.138% |
| Tilray Brands, Inc. | -244.98 Million USD | 84.987% |
| PetIQ, Inc. | 2.13 Million USD | 1825.95% |
| Talphera, Inc. | -18.39 Million USD | -99.924% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 114.73% |
| Alimera Sciences, Inc. | -20.13 Million USD | -82.694% |
| Assertio Holdings, Inc. | -331.94 Million USD | 88.92% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -457.888% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 77.052% |
| Hempacco Co., Inc. | -13.12 Million USD | -180.205% |
| Alvotech | -551.73 Million USD | 93.334% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 111.259% |
| Kamada Ltd. | 8.28 Million USD | 543.988% |
| Currenc Group, Inc. | -15.3 Million USD | -140.289% |
| Indivior PLC | 2 Million USD | 1939.0% |
| Evoke Pharma, Inc. | -7.79 Million USD | -372.005% |
| Flora Growth Corp. | -57.03 Million USD | 35.514% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -83.375% |
| Evolus, Inc. | -61.68 Million USD | 40.374% |
| HUTCHMED (China) Limited | 100.78 Million USD | 136.495% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 126.74% |
| Akanda Corp. | -32.27 Million USD | -13.958% |